We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 907

USPTO proposes extensive changes to AIA post-grant proceedings
  • Foley & Lardner LLP
  • USA
  • August 19 2015

Today the USPTO released a 113-page set of proposed changes to AIA post-grant proceedings, including IPR, PGR and CBM proceedings. The USPTO has been


Sequenom seeks rehearing en banc
  • Foley & Lardner LLP
  • USA
  • August 18 2015

Sequenom, Inc. has filed a petition for rehearing en banc of the Federal Circuit decision that held its diagnostic method claims invalid under 35 USC


Lessons learned from the 1st successful pharmaceutical IPR defense of Orange Book listed patents
  • Foley & Lardner LLP
  • USA
  • August 18 2015

In three petitions filed on the same day in 2013, styled Amneal v. Supernus, Amneal filed what appears to be the first challenge of Orange Book


Two bites, taken together: parallel and serial IPR petitions
  • Foley & Lardner LLP
  • USA
  • August 17 2015

As the body of institution and final decisions in Inter Partes Review (IPR) trials grows, useful trends at both decision stages can be identified


The value of prophetic examples
  • Foley & Lardner LLP
  • USA
  • August 13 2015

In Allergan, Inc. v. Sandoz, Inc., the Federal Circuit affirmed the district court decision that upheld the validity of the Allergan patents relating


Lumigan patents upheld by unexpected results
  • Foley & Lardner LLP
  • USA
  • August 11 2015

In Allergan, Inc. v. Sandoz, Inc., the Federal Circuit affirmed the district court decision that upheld the validity of the Allergan patents relating


An invalidity argument without a home? The PTAB's discretion to ignore grounds for invalidity
  • Foley & Lardner LLP
  • USA
  • August 10 2015

The post-grant proceedings established by the America Invents Act Inter Partes Review (IPR), Covered Business Method (CBM) review, and post-grant


Self-driving cars - "IP driving acquisition"
  • Foley & Lardner LLP
  • USA
  • August 6 2015

As Chair of Foley & Lardner’s Electronics Practice Group, I recently published a LinkedIn article about news reports of a group of German auto


Does spike in IPR settlements signify petitioner success?
  • Foley & Lardner LLP
  • USA
  • August 5 2015

The most recent IPR statistics have shown a sharp increase in the number of settlements, both before and after institution decisions, as revealed in


District court finds enhanced patent indefiniteness
  • Foley & Lardner LLP
  • USA
  • August 4 2015

I don't usually write about district court decisions, but the patent indefiniteness ruling inAndrulis Pharmaceuticals Corp. v. Celgene Corp. (D. Del